Gene · 4065
Papers1,798
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,798
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epoxy-oxylipins direct monocyte fate in inflammatory resolution in humans. | Nat Commun | 2026 | 41545341 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical Outcome. | J Invest Dermatol | 2026 | 40749971 | PubTator, text mining | PubMed |
| TIMP4 as a Potential Complementary Biomarker and Therapeutic Target in Membranous Nephropathy: A Multi-Omics Investigation with Clinical Validation. | J Inflamm Res | 2025 | 41169458 | PubTator, text mining | PubMed |
| Novel Strategies for Developing Next-Generation Vaccines to Combat Infectious Viral Diseases. | Vaccines (Basel) | 2025 | 41012182 | PubTator, text mining | PubMed |
| Nanovaccines: Innovative Advances from Design Strategies to Clinical Translation. | Vaccines (Basel) | 2025 | 41012106 | PubTator, text mining | PubMed |
| Broad-spectrum vaccines against various and evolving viruses: from antigen design to nanoparticle delivery. | J Virol | 2025 | 40938098 | PubTator, text mining | PubMed |
| An iPSC-based in vitro model recapitulates human thymic epithelial development and multi-lineage specification. | Nat Commun | 2025 | 40855082 | PubTator, text mining | PubMed |
| Transforming Cancer Nanotechnology Data Analysis and User Experience. Part I: Current Challenges and Solutions Provided by caNanoLab. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2025 | 40826521 | PubTator, text mining | PubMed |
| Checkpoint immunotherapy is associated with preferential activation of tumor antigen-specific CD4+ T cells in MDS. | Blood Neoplasia | 2025 | 40809194 | PubTator, text mining | PubMed |
| Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. | Signal Transduct Target Ther | 2025 | 40739089 | PubTator, text mining | PubMed |
| Identification of host cell surface proteins inhibiting furin dependent proteolytic processing of viral glycoproteins. | Sci Rep | 2025 | 40659811 | PubTator, text mining | PubMed |
| Diclofenac Immune-Mediated Hepatitis: Identification of Innate and Adaptive Immune Responses at Clinically Relevant Doses. | Int J Mol Sci | 2025 | 40565363 | PubTator, text mining | PubMed |
| The Role of Pattern Recognition Receptors in Epigenetic and Metabolic Reprogramming: Insights into Trained Immunity. | J Inflamm Res | 2025 | 40535352 | PubTator, text mining | PubMed |
| New therapeutic targets and mechanisms of papillary thyroid carcinoma identified by multi-omics analysis. | Discov Oncol | 2025 | 40338406 | PubTator, text mining | PubMed |
| Multi-Epitope DC Vaccines with Melanoma Antigens for Immunotherapy of Melanoma. | Vaccines (Basel) | 2025 | 40333215 | PubTator, text mining | PubMed |
| Site-directed multivalent conjugation of antibodies to ubiquitinated payloads. | Nat Biomed Eng | 2025 | 40204992 | PubTator, text mining | PubMed |
| Enhanced Cancer Immunotherapy by Bacterial Cytoplasmic Membranes Coated Nanovaccines for Co-Delivery of Ovalbumin Antigen and Immune Adjuvants to Dendritic Cells in Lymph Nodes. | Int J Nanomedicine | 2025 | 40007905 | PubTator, text mining | PubMed |
| DNA origami vaccine (DoriVac) nanoparticles improve both humoral and cellular immune responses to infectious diseases. | bioRxiv | 2025 | 38260393 | PubTator, text mining | PubMed |
| Identification of signatures associated with microsatellite instability and immune characteristics to predict the prognostic risk of colon cancer. | Open Med (Wars) | 2024 | 39726813 | PubTator, text mining | PubMed |
| Development of a Versatile Cancer Vaccine Format Targeting Antigen-Presenting Cells Using Proximity-Based Sortase A-Mediated Ligation of T-Cell Epitopes. | Bioconjug Chem | 2024 | 39511711 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4065/papers?page=2